YDES · CIK 0002011674 · FY2025 live · 2025-12-31
YD Bio Ltd
View as
Model
Z″
FY2025
−1.35
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−1.35
Classic Z −1.66
Z″ −1.35 · distress below 1.10, grey to 2.60, safe above.
Z″ factor contributions
X1 Working capital / assets
Short-term liquidity. Carries more weight in Z″ than in classic Z.
0.586.56 × = 3.82X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−0.743.26 × = −2.42X3 EBIT / assets
Operating return on assets. Highest weight in Z″.
−0.386.72 × = −2.57X4 Book equity / liabilities
Book equity versus the liability stack. Sales / assets is omitted so asset-light names are not punished for turnover.
−0.171.05 × = −0.18
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
YD Bio Ltd is on Z″ at −1.35 (distress) for FY2025, from an SEC 10-K. Working capital / assets is the line that sets the print; EBIT / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Z″ drops sales/assets so asset-light names are not punished for turnover. X4 is book equity on every name.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Z″ scores · 29th percentile in Healthcare.
- FRNMDistressFreenome, Inc.−1.36
- CAIDistressCaris Life Sciences, Inc.−0.93
- WBADistressWalgreens Boots Alliance, Inc.−0.77
- CDNADistressCareDx, Inc.−0.76
- AIRSDistressAirsculpt Technologies, Inc.−0.63
- SNDADistressSONIDA SENIOR LIVING, INC.−2.11
- HCADistressHCA Healthcare, Inc.−0.46
- AVAHDistressAveanna Healthcare Holdings, Inc.−0.46
KPI widgets
Current assets
$10M
Total assets
$14M
Current liabilities
$2M
Total liabilities
$17M
Working capital
$8M
Retained earnings
−$10M
EBIT
−$5M
Total sales
$597K
Book equity
−$3M
Accession 0001213900-26-050282. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Z″ is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.